12,359 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Capital International Sarl

Capital International Sarl acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 12,359 shares of the company’s stock, valued at approximately $1,014,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Laurel Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter worth about $27,000. Godfrey Financial Associates Inc. purchased a new position in shares of GE HealthCare Technologies in the 4th quarter worth about $27,000. Montag A & Associates Inc. increased its position in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the last quarter. Finally, Maseco LLP bought a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $29,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $64.67 on Monday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The stock has a market capitalization of $29.42 billion, a PE ratio of 15.47, a PEG ratio of 1.46 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The business’s 50-day moving average is $66.89 and its 200 day moving average is $75.52.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently commented on GEHC. Jefferies Financial Group reduced their price objective on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Argus reduced their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and reduced their price objective for the company from $75.00 to $69.00 in a research report on Thursday, May 21st. The Goldman Sachs Group lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $81.00 to $65.00 in a research report on Thursday, April 30th. Finally, JPMorgan Chase & Co. reduced their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $80.21.

Insider Buying and Selling

In other GE HealthCare Technologies news, Director Kevin Lobo bought 10,000 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The shares were bought at an average cost of $64.18 per share, with a total value of $641,800.00. Following the completion of the purchase, the director directly owned 14,363 shares of the company’s stock, valued at $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Rodney F. Hochman bought 1,618 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was acquired at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares of the company’s stock, valued at $100,364.54. The trade was a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 21,847 shares of company stock valued at $1,361,355 over the last ninety days. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.